午夜插插,噜噜噜影院,啪啪伊人网,欧美熟夫,景甜吻戏视频,男人强操性感蕾丝美女视频在线网站,日本美女跳舞视频

返回ChemicalBook首頁>CAS數(shù)據(jù)庫列表>251356-45-3

251356-45-3

中文名稱 化合物 T16947
英文名稱 SU 16f
CAS 251356-45-3
分子式 C24H22N2O3
分子量 386.44
MOL 文件 251356-45-3.mol
更新日期 2025/01/20 14:02:14
251356-45-3 結(jié)構(gòu)式 251356-45-3 結(jié)構(gòu)式

基本信息

中文別名
化合物SU16F
化合物 T16947
英文別名
SU 16f
PDGFR Tyrosine Kinase Inhibitor VII - CAS 251356-45-3 - Calbiochem
(Z)-3-(2,4-Dimethyl-5-((2-oxo-6-phenylindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid
5-[1,2-Dihydro-2-oxo-6-phenyl-3H-indol-3-ylidene)methyl]-2,4-dimethyl-1H-pyrrole-3-propanoicacid
1H-Pyrrole-3-propanoic acid, 5-[(1,2-dihydro-2-oxo-6-phenyl-3H-indol-3-ylidene)methyl]-2,4-dimethyl-

物理化學(xué)性質(zhì)

沸點(diǎn)661.7±55.0 °C(Predicted)
密度1.292±0.06 g/cm3(Predicted)
儲存條件Store at RT
溶解度Soluble to 100 mM in DMSO
酸度系數(shù)(pKa)4?+-.0.10(Predicted)
形態(tài)暗橙色固體
顏色Yellow to orange

常見問題列表

生物活性
SU16f 是有效的,選擇性 PDGFRβ 抑制劑,對 PDGFRβ,PDGFR1,PDGFR2 的 IC50 分別為 10 nM,140 nM,2.29 μM。SU16f 抑制 PDGFRβ 受體從而可以阻斷胃癌來源的間充質(zhì)干細(xì)胞 (GC-MSC) 條件培養(yǎng)基在胃癌細(xì)胞增殖和遷移中的促進(jìn)作用。
靶點(diǎn)

PDGFRβ

10 nM (IC 50 )

PDGFR2

140 nM (IC 50 )

PDGFR1

2.29 μM (IC 50 )

體外研究

SU16f (20 μM; for 8 hours) pretreatment inhibits the promoting role of GC-MSC-CM in SGC-7901 cell proliferation.
SU16f (20 μM; for 8 hours) significantly abolishes PDGFRβ activation in SGC-7901 by GC-MSC-CM. SU16f pretreatment results in the upregulation of E-cadherin and downregulation of N-cadherin, Vimentin, and α-SMA. SU16f pretreatment leads to downregulation of p-AKT, Bcl-xl, and Bcl-2 levels and upregulation of Bax expression in SGC-7901 cells by GC-MSC-CM .

Cell Proliferation Assay

Cell Line: SGC-7901 cells in GC-MSC/SGC-7901 co-culture system
Concentration: 20 μM
Incubation Time: 8 hours
Result: Inhibited the promoting role of GC-MSC-CM in SGC-7901 cell proliferation.

Western Blot Analysis

Cell Line: SGC-7901 cells
Concentration: 20 μM
Incubation Time: 8 hours
Result: Significantly abolished PDGFRβ activation in SGC-7901 by GC-MSC-CM, and resulted in the upregulation of E-cadherin and downregulation of N-cadherin, Vimentin, and α-SMA.
"251356-45-3" 相關(guān)產(chǎn)品信息